By suppressing the elevated expression of SPARC, we may be able to reduce the excessive proliferation of NSCs that occurs in cases like that of melanoma cells, where SPARC-acquired expression increases their survival by suppressing p53 and the subsequent inhibition of the apoptotic pathway [40]. The gene discussed is TP53; the disease is melanoma.